Esperion Therapeutics
ESPR
#6991
Rank
โ‚น36.68 B
Marketcap
โ‚น186.20
Share price
0.69%
Change (1 day)
-5.14%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น12.30 Billion

According to Esperion Therapeutics's latest financial reports the company has โ‚น12.30 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น6.84 B-50.41%
2022-12-31โ‚น13.80 B-28.47%
2021-12-31โ‚น19.30 B-13.45%
2020-12-31โ‚น22.30 B55.77%
2019-12-31โ‚น14.31 B50.54%
2018-12-31โ‚น9.51 B-25.6%
2017-12-31โ‚น12.78 B-11.09%
2016-12-31โ‚น14.37 B1.93%
2015-12-31โ‚น14.10 B110.28%
2014-12-31โ‚น6.70 B80.78%
2013-12-31โ‚น3.71 B940.78%
2012-12-31โ‚น0.35 B328.98%
2011-12-31โ‚น83.11 M
2002-12-31โ‚น2.15 B-36.58%
2001-12-31โ‚น3.39 B3.47%
2000-12-31โ‚น3.27 B1177.03%
1999-12-31โ‚น0.25 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น52.85 B 329.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น79.11 B 542.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น846.15 B 6,776.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น832.93 B 6,669.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น21.23 B 72.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น21.96 B 78.53%๐Ÿ‡บ๐Ÿ‡ธ USA